Pine River Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Pine River Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8,500	Closed	-$503K	–	675
2015 Q3	$503K	Buy	+8,500	New	+$539K	0.01%	501
2015 Q2	–	Sell	-7,600	Closed	-$490K	–	685
2015 Q1	$490K	Buy	+7,600	New	+$476K	0.01%	512
2014 Q3	–	Sell	-48,772	Closed	-$2.44M	–	976
2014 Q2	$2.37M	Buy	+48,772	New	+$2.4M	0.04%	339

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Pine River Capital Management's BMY Position: Q4 2015 in Review

Pine River Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 8,500 shares — an estimated $503K sold.

Pine River Capital Management first reported a position in BMY in Q2 2014 and held it in 3 quarters. The position peaked at $2.37M in Q2 2014. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Pine River Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
Pine River Capital Management sold 8,500 Bristol-Myers Squibb shares in Q4 2015, an estimated $503K.
Pine River Capital Management first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 3 quarters.
Pine River Capital Management's Bristol-Myers Squibb position peaked at $2.37M in Q2 2014.
1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Pine River Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.